AB
DERM icon

Amalgamated Bank’s Journey Medical DERM Stock Holding History

Amalgamated Bank’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-452
Closed -$3K – 1946
2025
Q4 		$3K Buy
452
+37
+9% +$290 ﹤0.01% 2840
2025
Q3 		$3K Hold
415
– – ﹤0.01% 2885
2025
Q2 		$3K Buy
+415
New +$2.87K ﹤0.01% 2905

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amalgamated Bank's DERM Position: Q1 2026 in Review

Amalgamated Bank sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 452 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in DERM in Q2 2025 and held it in 3 quarters. The position peaked at $3K in Q4 2025. 72 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Amalgamated Bank reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 452 Journey Medical shares in Q1 2026, an estimated $3K.
  • Amalgamated Bank first reported a position in Journey Medical in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Journey Medical position peaked at $3K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.